Use this form to request a free consultation with a qualified attorney near you.
ATTORNEY ADVERTISING -
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
-January 6, 2008
Recently, the Food and Drug Administration (FDA) approved a new fast-acting generic anesthesia, known as etomidate. Approved for use in short procedures, etomidate induces "conscious sedation," a state in which consciousness is dramatically depressed so patients feel sleepy/ relaxed during a medical procedure.
Also sold under the brand name Amidate, etomidate is produced by Parenta Pharma, an American pharmaceutical manufacturer based in South Carolina and Pennsylvania.
As an intravenous anesthesia, etomidate has a number of benefits, including that it:
Consequently, etomidate is ideal for use in emergency rooms, where immediate sedation that won't depress vital signs nor complicate current health problems is needed.
Specifically, etomidate is typically an ideal anesthesia for use in the following procedures:
When further, more invasive procedures are necessary, etomidate can be used in conjunction with more potent analgesic medications, powerful pain relievers that can fully sedate patients.
While etomidate can be a useful anesthesia in particular cases, this medication does have some associated side effects, including:
In rare cases, etomidate can cause severe allergic reactions. Injection-site inflammation, hives and facial swelling typically indicate that a person is severely allergic to etomidate.
Currently, etomidate is only available via prescription and can only legally be administered by a medical professional.
(Source: FDA)
Have you been harmed by a medication? If so, contact us today to talk to an experienced defective drug attorney who will provide you with the legal support you need to pursue your legal claim.